REXULTI (brexpiprazole) Patient Assistance Program
Don’t let the high cost of brand atypical antipsychotic therapy disrupt your treatment. We help eligible patients access Rexulti (brexpiprazole) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Rexulti (brexpiprazole) is FDA-approved for the treatment of schizophrenia in adults and pediatric patients (≥13 years), as adjunctive therapy to antidepressants for major depressive disorder (MDD) in adults, for agitation associated with Alzheimer's disease dementia, and for the treatment of post-traumatic stress disorder (PTSD) in combination with sertraline in adults.
- Without assistance, Rexulti costs commonly run approximately $1,500–$1,800 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Rexulti for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic Rexulti in the U.S. as of 2026. Many other atypical antipsychotics have generics available at very low cost — including aripiprazole (generic Abilify, structurally related), olanzapine, risperidone, quetiapine, ziprasidone, lurasidone (recent generic), and clozapine. For adjunctive MDD, lower-cost alternatives include adding aripiprazole, generic SGA, lithium, or thyroid hormone.
What Is Rexulti Prescription Assistance Program?
The Rexulti Prescription Assistance Program is a manufacturer-sponsored initiative that provides Rexulti at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for schizophrenia, MDD, Alzheimer’s agitation, and PTSD patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, psychiatry coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Rexulti costs roughly $1,500–$1,800/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$1,750 | Save ~$1,680/mo |
| CVS Pharmacy | ~$1,800 | Save ~$1,730/mo |
| Walmart | ~$1,600 | Save ~$1,530/mo |
| Costco | ~$1,550 | Save ~$1,480/mo |
Kroger | ~$1,580 | Save ~$1,510/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Rexulti Prescription Program?
The Patient Assistance Program is free to apply for and provides Rexulti at no medication cost if approved. Our $69.95/month service covers full advocacy. With many generic atypical antipsychotics available at very low cost (including generic aripiprazole, structurally related to Rexulti), generic alternatives are often the most affordable path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Rexulti:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $1,500–$1,800 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Rexulti assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Rexulti Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Rexulti:
Rexulti (brexpiprazole) is a once-daily oral atypical (second-generation) antipsychotic with a unique partial-agonist mechanism at dopamine and serotonin receptors. It is structurally and pharmacologically related to aripiprazole but with somewhat different receptor activity that may translate to less akathisia and other differences.
How Rexulti Works:
Brexpiprazole is an atypical antipsychotic that acts as a stabilizer of dopamine and serotonin signaling to modulate dysregulated neurotransmitter systems. It serves as a partial agonist at dopamine $D_2$, $D_3$, and serotonin $5\text{-HT}_{1\text{A}}$ receptors, while functioning as an antagonist at $5\text{-HT}_{2\text{A}}$ receptors. This mechanism allows it to provide antagonist-like effects during hyperdopaminergic states and agonist-like effects during hypodopaminergic states. Compared to aripiprazole, its lower intrinsic activity at $D_2$ receptors potentially reduces activation and akathisia while supporting efficacy in conditions like schizophrenia, MDD, Alzheimer’s agitation, and PTSD.
Form and use:
Rexulti is an oral medication taken once daily with or without food, with specific titration schedules based on the condition being treated. For schizophrenia, dosing starts at 1 mg daily and targets 2–4 mg, while adjunctive MDD begins at 0.5–1 mg daily up to a maximum of 3 mg. For Alzheimer’s agitation, it is titrated up to 2 or 3 mg daily, and for PTSD, it is used alongside sertraline with a target of 2–3 mg daily. Dose reductions are mandatory for patients who are CYP2D6 poor metabolizers or those taking strong CYP2D6 or CYP3A4 inhibitors.
Generic availability:
As of 2026, there is no generic version of Rexulti available in the United States. Patients seeking more affordable alternatives can access many other atypical antipsychotics as lower-cost generics, including risperidone, quetiapine, ziprasidone, olanzapine, clozapine, lurasidone, and the structurally related aripiprazole. For individuals requiring adjunctive treatment for MDD, cheaper and widely used options include adding generic aripiprazole, lithium, or thyroid hormone to therapy. The final choice of medication depends on specific clinical factors and individual patient needs.
Warnings:
Rexulti carries Boxed Warnings for increased mortality in elderly dementia patients and heightened suicidal thoughts and behaviors in young patients with MDD. Additional warnings encompass neuroleptic malignant syndrome, tardive dyskinesia, cerebrovascular events in elderly patients, and metabolic shifts like weight gain and hyperglycemia. It can also cause orthostatic hypotension, seizures, leukopenia, body-temperature dysregulation, falls, and dysphagia. Finally, patients have reported experiencing akathisia alongside impulse-control problems, such as pathological gambling, binge eating, or compulsive shopping.
FAQ (Frequently Asked Questions)
How Much Does Rexulti Cost Without Insurance?
Rexulti costs approximately $1,500–$1,800 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Rexulti at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Rexulti Different From Aripiprazole (Generic Abilify)?
Both are partial agonists at dopamine D2 and serotonin 5-HT1A receptors and antagonists at 5-HT2A. Brexpiprazole has lower intrinsic activity at D2 than aripiprazole — potentially producing less activation, less akathisia, and a smoother clinical profile for some patients. Generic aripiprazole is widely available at substantially lower cost. Many patients do well on generic aripiprazole; some may prefer Rexulti for tolerability.
Should I Try Generic Aripiprazole First?
Often yes — most insurance plans require trial of generic aripiprazole (or other generic atypicals) before approving Rexulti. Generic aripiprazole costs typically $10–$30/month, vs. ~$1,500–$1,800 for Rexulti. For many patients, generic aripiprazole works just as well. Discuss with your psychiatrist.
What About Rexulti For Alzheimer's Agitation?
Rexulti is FDA-approved specifically for agitation associated with Alzheimer’s dementia (the only antipsychotic with this specific approval as of 2023). However, the boxed warning about increased mortality in elderly with dementia-related psychosis still applies. Use should be limited to patients with significant agitation, after non-pharmacological measures have failed, with careful informed-consent discussion of risks vs. benefits.
What Should I Watch For?
Watch for metabolic side effects (weight gain, blood sugar elevation — regular monitoring needed), akathisia (restlessness), parkinsonism, tardive dyskinesia (irreversible movement disorder with long-term use — regular AIMS exams), orthostatic hypotension (lightheadedness when standing), impulse-control problems (pathological gambling, hypersexuality), and (rare) severe reactions. Tell your prescriber about any concerning symptoms.
Can I Get Rexulti Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic aripiprazole or another generic atypical (much cheaper), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the National Alliance on Mental Illness (NAMI), PAN Foundation, or HealthWell Foundation. State and county mental health services may also help. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Rexulti, our team may be able to help you access assistance programs — or guide you to generic aripiprazole or another generic atypical antipsychotic. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.